Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAP3K14 | Q99558 | 2/20 | 0.37 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | GPR6 | P46095 | 4/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18249606 | 0.91 | HDAC1 (0.45) | HDAC1HDAC2GPR119SMN1; SMN2USP30 | |
| SCHEMBL20164096 | 0.91 | GPR119 (0.45) | HDAC1HDAC2GPR119SMN1; SMN2MAP3K14 | |
| SCHEMBL20164081 | 0.82 | GPR6 (0.41) | GPR6 | |
| SCHEMBL18249644 | 0.82 | CES2 (0.44) | DPP4GPR6 | |
| SCHEMBL16818344 | 0.80 | GPR119 (0.55) | GPR119SMN1; SMN2MMP13DPP4GPR6 | |
| SCHEMBL16818241 | 0.80 | GPR119 (0.55) | GPR119SMN1; SMN2MMP13DPP4GPR6 | |
| SCHEMBL15566258 | 0.80 | GPR119 (0.55) | GPR119SMN1; SMN2MMP13DPP4GPR6 | |
| SCHEMBL15566031 | 0.80 | GPR119 (0.55) | GPR119SMN1; SMN2CYP3A4CYP3A5MMP13 | |
| SCHEMBL18249614 | 0.79 | MAP3K14 (0.39) | HDAC1HDAC2GPR119MAP3K14USP30 | |
| SCHEMBL18249631 | 0.79 | MMP13 (0.40) | GPR119MAP3K14USP30CYP3A4CYP3A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3297987-A1 | NOVEL AZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATHECOLAMINERGIC NEUROTRANSMISSION | Integrative Research Laboratories Sweden AB (SE) | 2018-03-28 | — | — | EP | disclosed |
| WO-2016185032-A1 | NOVEL AZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATHECOLAMINERGIC NEUROTRANSMISSION | INTEGRATIVE RESEARCH LABORATORIES SWEDEN AB (SE) | 2016-11-24 | — | — | WO | disclosed |